Your browser doesn't support javascript.
loading
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients.
de Marcellus, Charles; Tauziède-Espariat, Arnault; Cuinet, Aurélie; Pasqualini, Claudia; Robert, Matthieu P; Beccaria, Kevin; Puget, Stéphanie; Boddaert, Nathalie; Figarella-Branger, Dominique; De Carli, Emilie; Bourdeaut, Franck; Leblond, Pierre; Fouyssac, Fanny; Andre, Nicolas; Bertozzi, Anne I; Butel, Thibaut; Dufour, Christelle; Valteau-Couanet, Dominique; Varlet, Pascale; Grill, Jacques.
Afiliação
  • de Marcellus C; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France. charles.de-marcellus@aphp.fr.
  • Tauziède-Espariat A; Pediatric Intensive Care Unit, Necker-Enfants Malades University Hospital Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France. charles.de-marcellus@aphp.fr.
  • Cuinet A; Department of Neuropathology, GHU Psychiatrie et Neurosciences, site Sainte-Anne, Paris, France.
  • Pasqualini C; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Robert MP; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Beccaria K; Department of Ophthalmology, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Descarte, Paris, France.
  • Puget S; Borelli Centre UMR 9010, CNRS-SSA-ENS Paris Saclay-Paris University, Paris, France.
  • Boddaert N; Department of Pediatric Neurosurgery, Necker-Enfants Malades University Hospital, Assistance Publique- Hôpitaux de Paris, Paris, France.
  • Figarella-Branger D; Department of Pediatric Neurosurgery, Necker-Enfants Malades University Hospital, Assistance Publique- Hôpitaux de Paris, Paris, France.
  • De Carli E; Paediatric Radiology Department, AP-HP, Hôpital Necker Enfants Malades, Université de Paris, 75015, Paris, France.
  • Bourdeaut F; Université de Paris, Institut Imagine INSERM U1163, 75015, Paris, France.
  • Leblond P; APHM, CHU Timone, Department of Pathology and Neuropathology and Aix-Marseille Univ, CNRS, INP Inst Neurophysiopathol, Marseille, France.
  • Fouyssac F; Department of Pediatric Oncology, Angers University Hospital, Angers, France.
  • Andre N; SIREDO Center (Pediatric, Adolescent and Young Adults Oncology), Institut Curie, University of Paris, Paris, France.
  • Bertozzi AI; Pediatric Oncology Unit, Oscar Lambret Comprehensive Cancer Center, Lille, France.
  • Butel T; Department of Pediatric Hematology, Nancy University Hospital, Vandoeuvre-les-Nancy, France.
  • Dufour C; Department of Pediatric Hematology and Oncology, Aix Marseille Universityy, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
  • Valteau-Couanet D; Department of Hematology-Oncology, Children University Hospital, Toulouse, France.
  • Varlet P; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Grill J; Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, University Paris-Saclay, Villejuif, France.
J Neurooncol ; 157(2): 355-364, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35239111

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Ano de publicação: 2022 Tipo de documento: Article